New data highlighting the efficacy and safety outcomes of third‐generation EGFR‐TKI in NSCLC patients with rare EGFR mutations

• Weisan Zhang,
• Fengtan Li,
• Wenyuan Gao

Affiliations

Weisan Zhang

School of Pharmaceutical Science and Technology Tianjin University Tianjin China

Fengtan Li

Department of Radiology Tianjin Medical University General Hospital Tianjin China

Wenyuan Gao

School of Pharmaceutical Science and Technology Tianjin University Tianjin China